Tag: VAP
Early Oseltamivir Therapy Improves the Outcome in Critically Ill with Influenza
This real-life study emphasizes oseltamivir efficacy on in-hospital outcome when administrated within 2 days of the onset of symptoms. Even if physicians' awareness of the influenza disease has been undeniably enhanced... read more
How to Remove the Grey Area Between VAP and VAT?
We read with great interest the study performed by Paula Ramirez and colleagues. The study included 71 patients with ventilator-associated pneumonia (VAP) and the authors coined a new term called "gradual VAP".... read more
A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative VAP
Clinical failures in ventilator-associated pneumonia (VAP) caused by gram-negative bacteria are common and associated with substantial morbidity, mortality, and resource utilization. In this trial of adjunctive aerosol therapy... read more
The impact of oral care on oral health status and prevention of VAP in critically ill patients
Ventilator-associated pneumonia (VAP) is one of the most common nosocomial infections which increase mortality rate and length stay of hospitalization. Oral care would not only improve patient’s oral health and well-being,... read more
Ultra-Short-Course Antibiotics for Patients With Suspected Ventilator-Associated Pneumonia but Minimal and Stable Ventilator Settings
Many patients started on antibiotics for possible ventilator-associated pneumonia (VAP) do not have pneumonia. Patients with minimal and stable ventilator settings may be suitable candidates for early antibiotic discontinuation.... read more
National ICU Quality Indicators Revisited
The use of QI at a national level is a suitable method to focus on quality in healthcare. Independently of public access to the results, a local or national ICU network will have a lot to gain from engaging in the process... read more
New Infection Data and Sepsis-Guideline Critique at SCCM
The potential of probiotics to reduce nosocomial infections and ventilator-associated pneumonia in the critically ill and the latest data on readmissions will be among the major research advances presented here at the Society... read more
Antibiotic therapy advances in the critically ill
Key issues related to antibiotic management in the critically ill, including problems associated with timing, duration, and dosing of antibiotics. The authors highlighted the importance of early diagnosis of infection and... read more
Pneumonia Rates Linked to Hospital Ventilators Have Not Dropped, Says Study
Contrary to data published by the CDC, a study led by a UConn Health researcher concluded that ventilator-associated pneumonia is still a significant risk to patients.... read more
OCT may speed detection of pneumonia-related bacteria in ICU patients
The ability to better detect and assess bacteria linked to a form of pneumonia prevalent in hospital intensive care units (ICUs) could soon become possible, according to research reported in the latest issue of the Journal... read more
Greater collaboration between ICU nurses and ICU physicians may minimize VAP risk
Greater collaboration between ICU nursing and medicine could help to minimize ventilator-associated pneumonia (VAP), according to a study presented at the ATS 2016 International Conference.... read more
Driving Risk Factors Behind Ventilator-Associated Pneumonia
Ventilators that help patients breathe can be life-saving devices; however, they also have the power to cause deadly ventilator-associated pneumonia (VAP).... read more
